ISLAMABAD: The Drug Regulatory Authority of Pakistan (DRAP) has launched an innovative e-service, aimed at streamlining the registration process for pharmaceutical and biological products, covering various aspects such as local manufacturing, as well as the import and export of these items, integrating licencing operations for the manufacturers.
This move is a key part of DRAP's transformation strategy aimed at maintaining the highest standards of quality, safety, and efficacy of therapeutic goods in Pakistan.
Applicants are expected to adhere to standardised data submission formats, which can be found in the documents, including data submission formats for licensing operations of pharmaceutical manufacturers, registration of human drugs, renewal of registration of human drugs and variation in registration of human drugs.
The newly introduced e-service allows applicants to electronically submit their data through the eAPP portal, which is accessible after creating an account with DRAP.
This digital platform brings several benefits, including expedited and simplified data submission and processing, a significant reduction in paperwork, and the elimination of redundant processes. Additionally, it enhances transparency and visibility throughout the registration procedure.
This marks a milestone in the licencing and registration process, ushering in a new era of efficiency and effectiveness within the regulatory framework of Pakistan.
